RNAi News and Research

RSS
Researchers demonstrate important functional role of lincRNA in immune system

Researchers demonstrate important functional role of lincRNA in immune system

Alnylam reports new results from investigational RNAi therapeutic programs

Alnylam reports new results from investigational RNAi therapeutic programs

First CRISPR/Cas9 screen helps identify human proteins required for Zika virus replication

First CRISPR/Cas9 screen helps identify human proteins required for Zika virus replication

RVFV uses cancer pathway to hijack host cell and cause infection

RVFV uses cancer pathway to hijack host cell and cause infection

High-throughput RNA interference screen identifies potential drug target against henipaviruses

High-throughput RNA interference screen identifies potential drug target against henipaviruses

IMP's Johannes Zuber receives German Cancer Prize 2016

IMP's Johannes Zuber receives German Cancer Prize 2016

RXi Pharmaceuticals begins Phase 1/2 clinical trial in ophthalmology

RXi Pharmaceuticals begins Phase 1/2 clinical trial in ophthalmology

Alnylam presents positive ongoing phase 2 open-label extension data for Patisiran and Revusiran

Alnylam presents positive ongoing phase 2 open-label extension data for Patisiran and Revusiran

RXI-109 use after scar revision surgery has beneficial effect on suppression of hypertrophic scarring

RXI-109 use after scar revision surgery has beneficial effect on suppression of hypertrophic scarring

Study demonstrates effectiveness of new approach to protect humans from infectious disease

Study demonstrates effectiveness of new approach to protect humans from infectious disease

RAB35 protein plays role in oncogenic process

RAB35 protein plays role in oncogenic process

IDT webinar explores effective RNAi and antisense oligo methods

IDT webinar explores effective RNAi and antisense oligo methods

Trends, R&D progress, and predicted revenues in RNAi therapies

Trends, R&D progress, and predicted revenues in RNAi therapies

Alnylam presents positive Phase 1 ALN-AT3 trial results in hemophilia at ISTH 2015 Congress

Alnylam presents positive Phase 1 ALN-AT3 trial results in hemophilia at ISTH 2015 Congress

RXi Pharmaceuticals receives Notice of Allowance from USPTO for novel, self-delivering RNAi platform

RXi Pharmaceuticals receives Notice of Allowance from USPTO for novel, self-delivering RNAi platform

IDT to host instructive talk on accelerating synthetic biology at ASM General Meeting

IDT to host instructive talk on accelerating synthetic biology at ASM General Meeting

Alnylam files clinical trial application for alpha-1 liver disease, presents data at DDW

Alnylam files clinical trial application for alpha-1 liver disease, presents data at DDW

Fifth patient dosed in Benitec's TT-034 Phase I/IIa clinical trial for prevention of HCV infection

Fifth patient dosed in Benitec's TT-034 Phase I/IIa clinical trial for prevention of HCV infection

Alnylam announces clinical data from patisiran Phase 2 OLE study for treatment of patients with FAP

Alnylam announces clinical data from patisiran Phase 2 OLE study for treatment of patients with FAP

Myc cancer gene allows tumor cells to divide, provokes cell suicide process

Myc cancer gene allows tumor cells to divide, provokes cell suicide process